Dr Hanadi Bu-ali, MD | |
201 N Mayfair Rd, 3rd Floor, Wauwatosa, WI 53226-4216 | |
(414) 256-1920 | |
(414) 256-1921 |
Full Name | Dr Hanadi Bu-ali |
---|---|
Gender | Female |
Speciality | General Surgery |
Experience | 28 Years |
Location | 201 N Mayfair Rd, Wauwatosa, Wisconsin |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316069776 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 4301078926 (Michigan) | Secondary |
208600000X | Surgery | 35 . 089507 (Ohio) | Secondary |
208600000X | Surgery | 51735-020 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension Se Wisconsin Hospital - St Joseph Campus | Milwaukee, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Wheaton Franciscan Medical Group Inc | 8628980943 | 594 |
News Archive
Fitch Ratings assigns an 'F1+' short-term rating to the $60,900,000 Washington Health Care Facilities Authority variable rate revenue bonds, series 2002B (Catholic Health Initiatives). The short-term 'F1+' rating is based on the liquidity support of a standby bond purchase agreement (SBPA) provided by JPMorgan Chase Bank, N.A. The long-term rating (currently 'AA') continues to be based on the rating assigned to the Catholic Health Initiatives revenue bonds.
An initial gene analysis may yield better outcomes when patients are treated with the antipsychotic drugs risperidone and aripiprazole.
NeoTract, Inc., today announced that the first patient in the United States has been treated with its commercial UroLift System, the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia in men 50 years of age or older.
Columbia University Irving Medical Center, its Herbert Irving Comprehensive Cancer Center, and Pfizer Inc. have established the Columbia-Pfizer Clinical Trials Diversity Initiative, with the aim of reducing health disparities by increasing the participation of underrepresented minorities in clinical trials and enhancing the diversity of clinical researchers.
› Verified 4 days ago
Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
Fitch Ratings assigns an 'F1+' short-term rating to the $60,900,000 Washington Health Care Facilities Authority variable rate revenue bonds, series 2002B (Catholic Health Initiatives). The short-term 'F1+' rating is based on the liquidity support of a standby bond purchase agreement (SBPA) provided by JPMorgan Chase Bank, N.A. The long-term rating (currently 'AA') continues to be based on the rating assigned to the Catholic Health Initiatives revenue bonds.
An initial gene analysis may yield better outcomes when patients are treated with the antipsychotic drugs risperidone and aripiprazole.
NeoTract, Inc., today announced that the first patient in the United States has been treated with its commercial UroLift System, the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia in men 50 years of age or older.
Columbia University Irving Medical Center, its Herbert Irving Comprehensive Cancer Center, and Pfizer Inc. have established the Columbia-Pfizer Clinical Trials Diversity Initiative, with the aim of reducing health disparities by increasing the participation of underrepresented minorities in clinical trials and enhancing the diversity of clinical researchers.
› Verified 4 days ago
Entity Name | The Medical College Of Wisconsin Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
Fitch Ratings assigns an 'F1+' short-term rating to the $60,900,000 Washington Health Care Facilities Authority variable rate revenue bonds, series 2002B (Catholic Health Initiatives). The short-term 'F1+' rating is based on the liquidity support of a standby bond purchase agreement (SBPA) provided by JPMorgan Chase Bank, N.A. The long-term rating (currently 'AA') continues to be based on the rating assigned to the Catholic Health Initiatives revenue bonds.
An initial gene analysis may yield better outcomes when patients are treated with the antipsychotic drugs risperidone and aripiprazole.
NeoTract, Inc., today announced that the first patient in the United States has been treated with its commercial UroLift System, the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia in men 50 years of age or older.
Columbia University Irving Medical Center, its Herbert Irving Comprehensive Cancer Center, and Pfizer Inc. have established the Columbia-Pfizer Clinical Trials Diversity Initiative, with the aim of reducing health disparities by increasing the participation of underrepresented minorities in clinical trials and enhancing the diversity of clinical researchers.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Hanadi Bu-ali, MD 201 N Mayfair Rd, 3rd Floor, Wauwatosa, WI 53226-4216 Ph: (414) 256-1920 | Dr Hanadi Bu-ali, MD 201 N Mayfair Rd, 3rd Floor, Wauwatosa, WI 53226-4216 Ph: (414) 256-1920 |
News Archive
Fitch Ratings assigns an 'F1+' short-term rating to the $60,900,000 Washington Health Care Facilities Authority variable rate revenue bonds, series 2002B (Catholic Health Initiatives). The short-term 'F1+' rating is based on the liquidity support of a standby bond purchase agreement (SBPA) provided by JPMorgan Chase Bank, N.A. The long-term rating (currently 'AA') continues to be based on the rating assigned to the Catholic Health Initiatives revenue bonds.
An initial gene analysis may yield better outcomes when patients are treated with the antipsychotic drugs risperidone and aripiprazole.
NeoTract, Inc., today announced that the first patient in the United States has been treated with its commercial UroLift System, the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia in men 50 years of age or older.
Columbia University Irving Medical Center, its Herbert Irving Comprehensive Cancer Center, and Pfizer Inc. have established the Columbia-Pfizer Clinical Trials Diversity Initiative, with the aim of reducing health disparities by increasing the participation of underrepresented minorities in clinical trials and enhancing the diversity of clinical researchers.
› Verified 4 days ago
Kun-tai Hsu, MD Surgery Medicare: Medicare Enrolled Practice Location: 1155 N Mayfair Rd Ste T2600, Wauwatosa, WI 53226 Phone: 414-955-4263 Fax: 414-955-6286 | |
Dr. James Allen Vanheest, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 201 N Mayfair Rd, Suite 535, Wauwatosa, WI 53226 Phone: 414-258-5130 Fax: 414-258-5150 | |
Dr. Jan Riecan, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 North Mayfair Road, Suite 410, Wauwatosa, WI 53226 Phone: 414-774-1919 | |
Dr. James Patrick Ketterhagen, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 204 N 86th St, Wauwatosa, WI 53226 Phone: 561-319-2133 Fax: 561-634-2015 | |
Edward B Smith, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3289 N Mayfair Rd, Wauwatosa, WI 53222 Phone: 414-771-7900 Fax: 414-607-6336 | |
Nelson Agustin Rodriguez Unda, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1155 N Mayfair Rd Ste T2600, Wauwatosa, WI 53226 Phone: 414-955-1000 Fax: 414-955-0183 |